Form D — Atlas Oncology Holdings Inc.
0002110866-26-000001 · filed Feb 25, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- 06b
- Reported offering amount
- $23,000,000
- Reported amount sold
- $23,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Atlas Oncology Holdings Inc.
- CIK
- 2110866
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 1316 ADAMS STREET
NASHVILLE, TN 37208 - Phone
- 615-864-0524
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Kate Barnard Roberts · Executive OfficerNashville, TN Find on LinkedIn ↗
-
Ian Chiang · DirectorNashville, TN Find on LinkedIn ↗
-
Tara Sullivan · DirectorNashville, TN Find on LinkedIn ↗
-
David Glaccum · Executive OfficerNashville, TN Find on LinkedIn ↗
-
Matt Kim · DirectorNashville, TN Find on LinkedIn ↗
-
Dave Fielding · DirectorNashville, TN Find on LinkedIn ↗
-
Todd Nice · Executive OfficerNashville, TN Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗